The global cell therapy market size is expected to reach a value of $7.92 billion by 2025, rising at a compound annual growth rate (CAGR) of 5.34% during the forecast period.
Growing worldwide interest in discovering and development of advanced therapy medicinal products that are based on genes, tissues, or cells is likely to spur the growth of the market, according to a new report by Grand View Research.
Key suggestions from the report:
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze